VHOSPITAL.CLINIC · Drug Reference
Duloxetine is a prescription antidepressant from the group called serotonin and noradrenaline reuptake inhibitors (SNRIs). It is used for depression, anxiety and nerve pain.
Duloxetine increases the levels of two chemical messengers, serotonin and noradrenaline, in the brain and spinal cord. This can improve mood and also reduce some types of pain signals.
Most side effects settle within the first few weeks. More serious side effects are rare.
This is not a complete list. Always tell your doctor or pharmacist about all medicines, supplements and herbal remedies you take. For dosing, follow your prescription and the leaflet that comes with your medicine.
Written from the official and peer-reviewed sources listed above. General information only, not medical advice. Last updated 2026-11-13.
Venlafaxine
Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat depression, anxiety, and certain pain conditions including fibromyalgia and neuropathy.
Desvenlafaxine
Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat depression, anxiety, and certain pain conditions including fibromyalgia and neuropathy.
Milnacipran
Milnacipran is a serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat depression, anxiety, and certain pain conditions including fibromyalgia and neuropathy.
Levomilnacipran
Levomilnacipran is a serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat depression, anxiety, and certain pain conditions including fibromyalgia and neuropathy.
Describe your symptoms and concerns and get a structured clinical assessment — possible causes, red flags, and recommended next steps.
Start Free AI Analysis →Medical Disclaimer: This drug reference is provided for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or qualified health provider before starting, stopping, or changing any medication. Sources are listed above.